SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-23-011836
Filing Date
2023-04-11
Accepted
2023-04-11 16:05:09
Documents
5
Period of Report
2023-04-11

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 362161
2 proxy_001.jpg GRAPHIC 291289
3 proxy_002.jpg GRAPHIC 219753
4 proxy_003.jpg GRAPHIC 164753
5 proxy_004.jpg GRAPHIC 148073
  Complete submission text file 0001493152-23-011836.txt   1498320
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39717 | Film No.: 23813440
SIC: 2834 Pharmaceutical Preparations